This course has expired. View available courses.
Endocrinology
Reducing Cardiovascular and Renal Risk in Type 2 Diabetes – More than just Glycaemic Control
DURATION
4 hrs
PROFESSION
Physician
# OF CREDITS
2
ACCREDITATION
RACGP CPD Program
EXPIRY DATE
2021-03-15
Type 2 diabetes (T2D), cardiovascular disease and chronic kidney disease (CKD) often occur together in individuals due to shared risk factors. General practitioners play a central role in T2D management, identifying those at risk and providing optimal management.
Faculty
Dr Gary Deed
MBBS, MRACGP
Professor Andrew Sindone
B. Med (Hons), MD, FRACP, FCSANZ, FNHFA
Dr Marwan Obaid
MBBS, BSc(Med), FRACP, MMed
Learning objectives
Upon completion of this program, participants will be able to:
- Describe the epidemiological and pathophysiological relationship between heart failure, chronic kidney disease and type-2 diabetes (T2D)
- Evaluate the risk or presence of cardiovascular and/or kidney disease when selecting treatment protocols for managing glycaemia in T2D and glucose-independent mechanisms of disease
- Implement appropriate management strategies for patients with T2D according to current national and international management guidelines
- Consider treatments for T2D which reduce CV and renal risk beyond glycaemic control
- Consider long-term patient wellbeing and safety regarding primary prevention of cardiovascular disease when selecting diabetes medicines
Accreditation
This Active Learning Module has been approved by RACGP CPD Program for 2 CPD points (per hour).
Members are able to claim CPD activity points for 2 points per hour through 'Quick log' on their RACGP CPD Dashboard.